A Food and Drug Administration advisory panel is recommending that the agency approve the first pill to protect people from getting infected with the HIV. The recommendation is being hailed as a potential milestone in the battle against the AIDs epidemic. If the Food and Drug Administration goes along with the recommendation, the drug would become the first to be approved to prevent HIV infections. Melissa Block talks to Rob Stein.
In what could mark a watershed in the fight against HIV/AIDS, a panel of experts recommended that the Food and Drug Administration give a green light to a pill that can cut the risk of infections.
The daily pill, Truvada, made by Gilead Sciences, combines two medicines that inhibit the reproduction of HIV. It's already approved as a treatment for HIV, but its use could soon expand to include protection of uninfected people.